Dr. Steinlauf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Gustave L Levy Pl
New York, NY 10029Phone+1 212-987-3100Fax+1 212-731-5210
Summary
- Dr. Steinlauf attended Brandeis University in Waltham, Massachusetts from 1983 to 1987. He attended Medical School at Downstate Medical School from 1987 to 1991. He served his internship and residency in Internal Medicine at Columbia-Presbyterian Medical Center from 1991 to 1994. After working for a year as an Assistant Clincal Professor of Medicine at Columbia-Presbyterian Medical Center, he became a fellow in Gastroenterology at Yale-New Haven Medical Center from 1995 to 1998. Dr. Steinlauf worked for two years in a multispecialty medical practice in New Jersey after wh ich he joined the practice of Present, Chapman, Marion & Steinlauf at Mount Sinai Medical Center. This practice specializes in the study, diagnosis and treatment of patients who suffer with IBD. He remained there from January of 2001 until July 2013 at which time he joined the Weill Cornell community as Director, Strategic Planning and Growth, Jill Roberts IBD Center. As of 2018, he is moving back to Mount Sinai Medical Center where he will see patients and serve as the Director of IBD Clinical Trial Recruitment.
Dr. Steinlauf has been involved in many clinical trials for IBD during his years at the Mount Sinai Medical Center, and st Weill Cornell Medical Center. He lectures widely on issues relating to IBD and is extensively published. He has earned many honors such as inclusion in: America's Top Physicians by the Consumers' Research Counsil of America (2007 to present), The Best Doctors in America by Best Doctors, Inc. (2009 to present), and New York Super Doctors by Key Professional Media, Inc. (2008 to present).
Dr. Steinlauf sees patients at Mount Sinai Medical Center as part of the Feinstein Center for Inflammatory Bowel Disease.
Education & Training
- Yale-New Haven Hospital1998
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1994
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1991 - 1992
- State University of New York Downstate Medical Center College of MedicineClass of 1991
- Brandeis UniversityBA, 1983 - 1987
Certifications & Licensure
- NY State Medical License 1993 - 2024
- CT State Medical License 1996 - 2001
- NJ State Medical License 1998 - 2001
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- New York Super Doctors Key Professional Media, 2008, 2009, 2010
- The Best Doctors in America Best Doctors, Inc, 2009 - 2010, 2010
- Join now to see all
Publications & Presentations
PubMed
- 216 citationsIgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote TH17-dependent inflammationMonica Viladomiu, Charles Kivolowitz, Ahmed Abdulhamid, Belgin Dogan, Daniel A. Victorio
Science Translational Medicine. 2017-02-08 - 20 citationsEfficacy and Safety of Dual Biologic Therapy in Patients With Inflammatory Bowel Disease: A Review of the LiteratureStephanie L. Gold, Adam F. Steinlauf
Gastroenterology & Hepatology. 2021-09-01 - 49 citationsLow-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements.Adam F. Steinlauf, Guadalupe Garcia-Tsao, Maram F. Zakko, Kevin W. Dickey, Tarun K. Gupta
Hepatology. 1999-04-01
Journal Articles
- Delays in Initiating Post-Operative Prophylactic Biologic Therapy Are Common Among Crohn’s Disease PatientsHeather Yeo, Adam Steinlauf, Stephanie Gold, Fabrizio Michelassi, Madison Dennis, Digestive Diseases and Sciences
- Chromoendoscopic Targeted Biopsies are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective E...Marion JF, Waye JD, Present DH, Israel Y, Bodian C, Harpaz N, Chapman M, Itzkowitz S, Steinlauf AF, Ullman TA, Aisenberg J, Mayer L, Am J. Gastroenterol
- Outcomes After Retreatment with Cyclosporine a (CsA) in Hospitalized Ulcerative Colitis (UC) Patients: A 7-Year Review from a Single Institution.Sauk J, Present DH, Kornbluth A, Lichtiger S, George J, Marion JF, Steinlauf AF, Legnani P, Weiss AA, Agarwal S, Rosen MH, Naymagon S, Ullman TA, Gastroenterology
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Neurogenetic Connection between the Control of Courtship Singing and Visual System Functions in Drosophila melanogaster.Kulkarni SJ, Vargo M, Steinlauf AF, Hall JC, Cold Spring Harbor Meeting on Molecular Neurobiology of Drosophila
- Effect of Midazolam Administration on Portal Venous Pressure Measurements.Steinlauf AF, Zakko MF, Dickey K, Gupta TK, Garcia-Tsao G, Groszmann RJ, Hepatology
- Idiopathic and Reflux Associated Diffuse Esophageal Spasm: A Lack of Differentiation by Manometry.Steinlauf AF, Sandman Y, Traube M, Gastroenterology
- Join now to see all
Lectures
- The Role of Anti-Neutrophil Cytoplasmic Autoantibodies in Inflammatory Bowel Disease.Yale University
- Diagnosis and Treatment of Diarrhea/Inflammatory Bowel Disease.Physicians Associate Program, Yale University School of Medicine
- Nutritional Management of Short Bowel Syndrome.Yale University
- Join now to see all
Other Languages
- Spanish
External Links
- Websitehttp://weillcornell.org/physician/asteinlauf/index.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: